LabCorp® LH, +2.45% a leading global life sciences company, and the Texas Association of Community Health Centers, Inc. (TACHC) a private, non-profit association of approximately 75 community health centers with more than 500 service locations across Texas serving the most vulnerable populations, today announced that they have entered into an agreement for LabCorp to be the exclusive preferred laboratory for TACHC.
This new agreement extends a relationship of more than 25 years and will provide enhanced laboratory services for more than one million patients who receive care from community health centers that are members of TACHC. LabCorp is a leading global life sciences company providing comprehensive laboratory services and end-to-end drug development services. TACHC is a private, non-profit association of approximately 75 community health centers with more than 500 service locations across Texas, which provides necessary health care services to the most vulnerable populations.
“For many years, our member health centers have depended on LabCorp to provide high-quality testing services for the patients they serve and we are pleased to extend our relationship with LabCorp,” said José E. Camacho, Esq., executive director and general counsel for TACHC. “We look forward to enhancing the scope of laboratory services that will be available to our clinicians, which will provide immediate and long-term benefits for the patients we serve every day. In particular, we expect that the use of data analytics will help us better address health trends across the populations we serve and that new programs for chronic diseases will have a positive impact on the lives and health of our patients.”
Under the new agreement, TACHC and LabCorp will use data analytics to identify population health trends, enabling focused community and individual outreach about screening, monitoring and treatment options for common health conditions. TACHC intends to make LabCorp’s Litholink clinical decision support programs available to its members, with the goal of improving the care of patients with chronic kidney disease and/or diabetes. Those programs provide targeted guidance for clinicians and patients about the most appropriate tests, treatments and lifestyle options. This patient-focused information supports better management of those conditions and can help improve patient outcomes and reduce costs.
“LabCorp can provide tailored solutions to meet the individualized needs of the patients our customers serve, and we are very excited to bring more of our experience to TACHC and its members,” said Bob Nelson, senior vice president for LabCorp Diagnostics’ Mid-America Division. “The community health centers that are part of TACHC do an incredible job serving the most vulnerable patients in many areas where there are no other healthcare options. Laboratory testing plays an important role in healthcare decision-making and we want to help TACHC’s patients gain access to the highest quality of care.”
